@article{Utami_Rahmawati_Patonah_Wahyudi_2022, title={Adverse Events Following Immunization (AEFI) of COVID-19 vaccines and their association with comorbidities in health personnel and public servants in Indonesia}, volume={8}, url={https://stikbar.org/ycabpublisher/index.php/PHI/article/view/587}, DOI={10.36685/phi.v8i2.587}, abstractNote={<p><strong>Background:</strong> Health workers and public servants as the front line in service are prioritized to get the COVID-19 vaccination. The phenomenon of side effects is a major issue in administering the vaccination.</p> <p><strong>Objective:</strong> The research aimed to identify Adverse Events Following Immunization (AEFIs) and their correlation with comorbidities in health workers and public servants in Indonesia.</p> <p><strong>Methods:</strong> A cross-sectional study design was used in this study among 262 participants selected using purposive sampling. Data were collected using Google Form. Univariate analysis and Chi-Square were used for data analysis.</p> <p><strong>Results:</strong> Of all participants, 74.8% were not comorbid, and 25.2% were comorbid. The incidence of AEFI was 56.9%, relatively occurring after the vaccination I, II, and I and II. AEFI started 40.1% within 24 hours post-vaccination with a 48.7% symptom duration within 1-24 hours. AEFI reactions 42.3% are other reactions in the form of allergic reactions, drowsiness, and increased appetite. The Chi-Square test showed a p-value of 0.894, indicating that both comorbid and non-comorbid patients had the same risk of developing AEFI.</p> <p><strong>Conclusion:</strong> Comorbid or non-comorbid is safe to get COVID-19 vaccination. Supervisors reporting on AEFI is important to anticipate the severity condition. Health protocols must be implemented continually.</p>}, number={2}, journal={Public Health of Indonesia}, author={Utami, Wiwik and Rahmawati, Rahmawati and Patonah, Siti and Wahyudi, Imam}, year={2022}, month={Jun.}, pages={39–45} }